E
AGIO icon

Ergoteles’s Agios Pharmaceuticals AGIO Stock Holding History

Ergoteles’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-53,129
Closed -$1.5M – 49
2023
Q2 		$1.5M Buy
53,129
+27,644
+108% +$688K 0.07% 346
2023
Q1 		$585K Buy
+25,485
New +$677K 0.02% 681
2022
Q3 		– Sell
-17,533
Closed -$389K – 1506
2022
Q2 		$389K Buy
17,533
+5,441
+45% +$123K 0.01% 971
2022
Q1 		$352K Sell
12,092
-53,732
-82% -$1.64M 0.01% 792
2021
Q4 		$2.16M Buy
+65,824
New +$2.65M 0.08% 245
2021
Q2 		– Sell
-76,419
Closed -$3.95M – 1463
2021
Q1 		$3.95M Buy
76,419
+34,907
+84% +$1.73M 0.12% 194
2020
Q4 		$1.8M Buy
41,512
+8,545
+26% +$338K 0.06% 262
2020
Q3 		$1.15M Buy
+32,967
New +$1.44M 0.15% 129

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return